www.gbt.com Open in urlscan Pro
35.185.31.195  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
 * Global+
   * Global
   * France
   * Germany
   * UK
 * Contact Us
 * twitter
 * LinkedIn

gbt
 * Global+
   * Global
   * France
   * Germany
   * UK
 * About+
   * Our Company
   * Leadership
   * Board of Directors
   * Contact Us
 * Our Commitment+
   * Patients & Advocacy
   * GBT’s Supported Conferences
   * COVID-19 Information and Resources
   * Corporate Giving
   * The GBT Foundation
   * Expanded Access
   * Environmental, Social and Governance
 * Research+
   * Sickle Cell Disease
   * Pipeline
   * Externally Sponsored Research (ESR)
   * Partnerships
   * Publications
 * Our Medicine
 * Investors & Media+
   * Company Summary
   * Media Resources
   * Press Releases
   * Events & Presentations
   * Quarterly Results
   * Analyst Coverage
   * Stock Information
   * SEC Filings
   * Governance
   * Investor FAQs
 * Careers+
   * Jobs
 * Contact Us
 * twitter
 * LinkedIn

Hope is what feeds us,

connects us and moves us forward. It’s what we bring to life through access to
innovative treatment and determined advocacy.

Learn more



Science is our bedrock, our backbone.

It’s how we make good happen and find ways to answer significant unmet needs.
It’s our promise.

Learn more

Community is our strength and our inspiration.

Patients, their families and healthcare professionals are why we come to work
each day and our reason for being.

Learn more
 * 
 * 
 * 


ADVANCING CARE IN SICKLE CELL DISEASE

We are changing the way treatments for sickle cell disease are developed,
approved and delivered

See our pipeline


PARTNERING WITH THE COMMUNITY

Our deep commitment to the sickle cell community includes helping to create
solutions to help improve the quality of care and access to treatment for
patients

More on our commitment


JOIN OUR PURPOSE-DRIVEN CULTURE

Every GBT colleague has an opportunity to make a difference for underserved
patients

Build your career

July 14, 2022
Press Release

GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell
Disease in Brazil

July 13, 2022
Press Release

The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease
Community-Based Organizations

July 7, 2022
Press Release

GBT Announces New Employment Inducement Grants

June 29, 2022
Press Release

GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell
Disease

June 16, 2022
Press Release

NFL Running Back Tevin Coleman and Family Team Up with GBT to Share Playbook for
Families Affected by Sickle Cell Disease

View latest news
gbt

Copyright 2021
Global Blood Therapeutics, Inc.

 * Privacy Policy
 * Online Tracking Opt-Out Guide
 * Terms of use
 * Community guidelines

P-VOX-US-00501

 * About
   * Our Company
   * Leadership
   * Board of Directors
   * Contact Us
   * Careers
 * Our Commitment
   * Patients & Advocacy
   * GBT’s Supported Conferences
   * COVID-19 Information and Resources
   * Corporate Giving
   * The GBT Foundation
   * Expanded Access
   * Environmental, Social and Governance
 * Research
   * Sickle Cell Disease
   * Pipeline
   * Externally Sponsored Research (ESR)
   * Partnerships
   * Publications
 * Our Medicine
 * Investors & Media
   * Company Summary
   * Media Resources
   * Press Releases
   * Events & Presentations
   * Quarterly Results
   * Analyst Coverage
   * Stock Information
   * SEC Filings
   * Governance
   * Investor FAQs
 * Careers
   * Jobs
 * Contact Us
 * twitter
 * LinkedIn

This site uses cookies to give you the best online experience. Learn more,
including how to disable certain cookies on our Privacy Page. Accept
Privacy & Cookies Policy
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these cookies, the cookies that are categorized as necessary
are stored on your browser as they are essential for the working of basic
functionalities...
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
This category only includes cookies that ensures basic functionalities and
security features of the website. These cookies do not store any personal
information.
Non-necessary
Non-necessary
Any cookies that may not be particularly necessary for the website to function
and is used specifically to collect user personal data via analytics, ads, other
embedded contents are termed as non-necessary cookies. It is mandatory to
procure user consent prior to running these cookies on your website.
SAVE & ACCEPT



×


YOU ARE NOW LEAVING THE GLOBAL BLOOD THERAPEUTICS WEBSITE

You are currently leaving our site. External links are being provided as a
convenience and for informational purposes only; they do not constitute an
endorsement or an approval by Global Blood Therapeutics. Are you sure you want
to proceed?
Okay Cancel